Sanofi (France)
Parent Company
174/180 Avenue de France
Paris
Cedex
75013
France
Tel: 33-1-53-77-4000
Website: http://www.sanofi-synthelabo.fr/
2154 articles about Sanofi (France)
-
Sanofi-Aventis (France) Calls Hundreds of Reps With Layoff News
12/3/2009
-
Serge Weinberg Tipped for Sanofi-Aventis (France) Chairman According to Report
11/30/2009
-
Sanofi-Aventis (France)'s Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
11/30/2009
-
FDA Warns Heartburn Drugs Interfere with Sanofi-Aventis (France), Bristol-Myers Squibb Company's (JOBS) Plavix
11/18/2009
-
Aureus Pharma Extends Its Knowledge Database Agreement with Sanofi-Aventis (France) R&D
11/5/2009
-
Bristol-Myers Squibb Company, Sanofi-Aventis (France) Prevail in Fight Over Plavix
11/3/2009
-
Sanofi-Aventis (France) Video Q&A: CEO Chris Viehbacher Comments on Q3 ’09 Earning and Outlook
10/30/2009
-
Sanofi-Aventis (France) Delivers a Solid Performance in Third Quarter 2009
10/30/2009
-
Sanofi-Aventis (France), Micromet Seal Early-Stage Cancer Drug Deal; Micromet Could Get Up to $475 Million
10/29/2009
-
Sanofi-Aventis (France) Release: Clinical Trial Logistics Strategies for Maximizing Efficiency, Safety and Regulatory Compliance Explored by Sanofi-Aventis (France), Pfizer Inc., AstraZeneca PLC, Schering-Plough Corporation, FDA, DHS and Global BioPharm S
10/29/2009
-
Sanofi-Aventis (France) Gets FDA Warning Over Uroxatral Promotion
10/28/2009
-
Sanofi-Aventis (France) to Create China Vitamin JV with Minsheng
10/26/2009
-
Sanofi (France) Buys Wellstat Therapeutics Corporation's Type II Diabetes Drug PN2034 For Up To $350 Million
10/21/2009
-
US Clears Sanofi-Aventis (France) Drug for Cancer Complication
10/19/2009
-
Sanofi-Aventis (France) to Buy Dyax Corp.'s (JOBS) Drug Development Partner, Fovea Pharmaceuticals
10/13/2009
-
Merial Invests $70 Million in Nanchang, China
10/12/2009
-
Sanofi-Aventis (France) CEO to Shop for Biotech, Vaccine, Nonprescription Deals
10/1/2009
-
Sanofi-Aventis (France) and Merrimack Pharmaceuticals Inc. Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121; Merrimack Eligible to Receive up to $530 Million
10/1/2009
-
Fovea Pharmaceuticals to be Acquired by Sanofi-Aventis (France) for up to $541 Million
10/1/2009
-
Sanofi Aventis Groupe: Superior Efficacy-dose Ratio for Lantus(R) Over detemir
9/30/2009